Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gemcis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00939848
What this trial is testing

Cediranib Versus Placebo Plus Cisplatin/Gemcitabine Chemotherapy for Patients With Advanced Biliary Tract Cancers

Who this might be right for
Biliary Tract Neoplasms
University College, London 124
Testing effectiveness (Phase 2)Study completedNCT03778593
What this trial is testing

FOLFIRINOX for 2nd-line Treatment of BTC

Who this might be right for
Biliary Tract Cancer
Dong-A University Hospital 34
Testing effectiveness (Phase 2)Study completedNCT00556621
What this trial is testing

Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer

Who this might be right for
Bladder Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 14
Testing effectiveness (Phase 2)Study completedNCT00191854
What this trial is testing

Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line

Who this might be right for
Breast Cancer
Eli Lilly and Company 147
Early research (Phase 1)UnknownNCT00005996
What this trial is testing

SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00004003
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Pancreatic Cancer
Barbara Ann Karmanos Cancer Institute 30
Testing effectiveness (Phase 2)UnknownNCT00561054
What this trial is testing

Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Grupo Portugues de Estudo do Cancro do Pulmao 47
Testing effectiveness (Phase 2)Study completedNCT01320254
What this trial is testing

PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine)

Who this might be right for
Cholangiocarcinomas
Hannover Medical School 93
Testing effectiveness (Phase 2)Study completedNCT01086254
What this trial is testing

SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IV
Sanofi 119
Not applicableLooking for participantsNCT06611345
What this trial is testing

Tumor-Treating Fields in Combination With Durvalumab and Gemcitabine/Cisplatin in Biliary Tract Cancers

Who this might be right for
Biliary Tract Cancers (BTC)
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03734809
What this trial is testing

NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer

Who this might be right for
NPC
Chinese University of Hong Kong 43
Early research (Phase 1)Study completedNCT01242605
What this trial is testing

ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract NeoplasmsCholangiocarcinomaGallbladder Neoplasms
University College, London 13
Testing effectiveness (Phase 2)Ended earlyNCT01939418
What this trial is testing

Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
National Cancer Center, Korea 23
Testing effectiveness (Phase 2)Ended earlyNCT00859339
What this trial is testing

Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC

Who this might be right for
Transitional Cell Carcinoma of the Bladder
Noah Hahn, M.D. 9
Testing effectiveness (Phase 2)Ended earlyNCT00924209
What this trial is testing

A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer

Who this might be right for
NSCLCStage IIIA (N2)
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Looking for participantsNCT07392541
What this trial is testing

Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Carcinoma
Tongji Hospital 29
Testing effectiveness (Phase 2)Study completedNCT00821327
What this trial is testing

Gemzar, Cisp, Sunitinib Urothelial Ca

Who this might be right for
Urothelial Cancer
US Oncology Research 36
Testing effectiveness (Phase 2)Ended earlyNCT03366766
What this trial is testing

Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung CarcinomaStage I Non-Small Cell Lung CancerStage IA Non-Small Cell Lung Carcinoma+5 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14
Large-scale testing (Phase 3)Looking for participantsNCT06037980
What this trial is testing

CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence

Who this might be right for
Biliary Tract CancerCholangiocarcinoma
Gruppo Oncologico del Nord-Ovest 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06037655
What this trial is testing

Chemotherapy Combined With Adebrelimab and Mecapegfilgrastim in Neoadjuvant Treatment of Potentially Resectable BTC

Who this might be right for
Biliary Tract Neoplasms
The First Affiliated Hospital with Nanjing Medical University 30
Next Page